Q.What does Oxygen Biotherapeutics do?
A.

Oxygen Biotherapeutics, Inc., is dedicated to commercializing innovative products in the field of oxygen therapeutics. The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte. The company believes Oxycyte has the potential for use in multiple areas, including traumatic brain injury, stroke, decompression sickness and wound healing.


Q.When was Oxygen Biotherapeutics established?
A.Synthetic Blood International, Inc. was established in 1990 and listed on the OTC-Bulletin Board. The company changed its name to Oxygen Biotherapeutics, Inc. on July 1, 2008. In January 2010, the company was listed on the NASDAQ under the ticker symbol OXBT.

Q.When does Oxygen Biotherapeutics fiscal year end?
A.April 30

Q.On which exchange does Oxygen Biotherapeutics trade and what is the symbol?
A.Oxygen Biotherapeutics trades on NASDAQ. The ticker symbol is OXBT.

Q.When did Oxygen Biotherapeutics become public?
A.The company became public in 1994 on the OTC-BB.

Q.How many shares are outstanding?
A.As of March 20, 2013, there were 38,305,765 shares of common stock outstanding.

Q.Does Oxygen Biotherapeutics issue dividends on its common stock?
A.No.

Q.Does Oxygen Biotherapeutics have a Direct Stock Purchase Plan or Dividend Reinvestment Plan (DRIP)?
A.No.

Q.When is the General Annual Meeting of Shareholders?
A.

September 20, 2013


Q.Who is Oxygen Biotherapeutics independent auditor?
A.Cherry, Bekaert & Holland LLP
2626 Glenwood Avenue
Raleigh, NC 27608

Q.Who can I contact regarding OXBT stock certificate matters?
A.Interwest Transfer Co.
1981 E. 48 South, Suite 100
P.O. Box 17136
Salt Lake City, UT 84117
Phone: (801) 272-9294
Fax: (801) 277-3147
www.interwesttc.com

Q.Who is Oxygen Biotherapeutics external legal counsel?
A.Smith, Anderson, Blount, Dorsett, Mitchell and Jernigan LLP
2500 Wachovia Capitol Center
150 Fayetteville Street
Raleigh, NC 27601

Q.Where are Oxygen Biotherapeutics headquarters?
A.Oxygen Biotherapeutics, Inc.
ONE Copley Parkway
Suite 490
Morrisville, NC 27560

Q.How can I receive info about the Company?
A.A lot of info is available on this website. Our 10-Q, 10-K and other regulatory filings can be found by clicking on the SEC Filings link. You may contact Investor Relations at (919) 855-2112 or send an info request to our corporate headquarters, Attention: Investor Relations.